The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ... single-patient-use pen that delivers doses of 0.6mg, 1.2mg, or 1.8mg in ...
Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...
(HealthDay News) — The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide ...
Hikma Pharmaceuticals received approval to manufacture a generic form of Novo Nordisk’s subcutaneous liraglutide 18 mg pens (Victoza). The treatment has been approved for children and adults ...
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide ... liraglutide pen sharing, hypoglycemia when used in conjunction with certain other drugs ...